Julie Safirstein

Statistics

Publications

Citations

179

H-Index

Active since

2020

Affiliations

Hospital of the University of Pennsylvania(Current)

Alberta Health Services

Children's Hospital of Philadelphia

University of Kentucky

Barnes-Jewish College

Julie Safirstein is an author at Hospital of the University of Pennsylvania specializing in elexacaftor therapy, ivacaftor therapy, and cystic fibrosis liver disease.

ORCID

Publications per year

2020–2022

Publications

Mental status changes during elexacaftor/tezacaftor / ivacaftor therapy

Suyeon Heo, David C. Young, Julie Safirstein et al. · Journal of Cystic Fibrosis · 2021 · 85 citations · Full text

Social Sciences, Psychiatry, Psychology +10

Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis

Julie Safirstein, Jonathan J. Grant, Emily Clausen et al. · Journal of Cystic Fibrosis · 2020 · 37 citations · Full text

Medicine, Internal Medicine, Surgery +13

The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series

Hunter Ragan, Elizabeth Autry, Taryn Bomersback et al. · Pediatric Pulmonology · 2021 · 27 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Drug-induced acne with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis

Brionna Hudson, Hollyann R. Jacobs, Alexander Philbrick et al. · Journal of Cystic Fibrosis · 2022 · 20 citations · Full text

Medicine, Dermatology, Pharmacology +12

The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis post-liver transplant: a case series

Hunter Ragan, Elizabeth Autry, Taryn Bomersback et al. · 2021 · 10 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 5